|
|
Volumn 67, Issue 4, 2015, Pages 599-602
|
|
SUCCINCT: An open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinoma
a
b,c
b
|
|
Author keywords
Advanced urothelial tract; Clinical trial; First line treatment; Phase 2; Sunitinib; transitional cell carcinoma
|
|
Indexed keywords
CISPLATIN;
GEMCITABINE;
SUNITINIB;
ANTINEOPLASTIC AGENT;
DEOXYCYTIDINE;
INDOLE DERIVATIVE;
PYRROLE DERIVATIVE;
ANEMIA;
ARTICLE;
BONE MARROW TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
DIARRHEA;
FATIGUE;
FEBRILE NEUTROPENIA;
HUMAN;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
MULTIPLE CYCLE TREATMENT;
NAUSEA;
NEUTROPENIA;
OPEN STUDY;
OVERALL SURVIVAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
SURVIVAL RATE;
SURVIVAL TIME;
THERAPY DELAY;
THROMBOCYTOPENIA;
TRANSITIONAL CELL CARCINOMA;
TREATMENT RESPONSE;
VOMITING;
AGED;
ANALOGS AND DERIVATIVES;
BONE MARROW DISEASE;
CHEMICALLY INDUCED;
CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
FEMALE;
MALE;
MIDDLE AGED;
PATHOPHYSIOLOGY;
TREATMENT OUTCOME;
UROLOGIC NEOPLASMS;
AGED;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE MARROW DISEASES;
CISPLATIN;
DEOXYCYTIDINE;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
INDOLES;
MALE;
MIDDLE AGED;
PYRROLES;
TREATMENT OUTCOME;
UROLOGIC NEOPLASMS;
|
|
EID: 84923130166
PISSN: 03022838
EISSN: 18737560
Source Type: Journal
DOI: 10.1016/j.eururo.2014.11.003 Document Type: Article |
|
Times cited : (26)
|
|
References (10)
|
